CAS 2765424-50-6

(4S)-4-({[2-({[({2-[2-({[({[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]methoxy}carbonyl)amino]sulfonyl}amino)ethoxy]ethoxy}carbonyl)amino]sulfonyl}[2-({[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propyl]carbamoyl}oxy)ethyl]amino)ethoxy]carbonyl}amino)-4-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

纯度 97%+现货药物标准品
CAS 号2765424-50-6
分子式C112H130F2N18O35S2
分子量2390.46 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(4S)-4-({[2-({[({2-[2-({[({[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]methoxy}carbonyl)amino]sulfonyl}amino)ethoxy]ethoxy}carbonyl)amino]sulfonyl}[2-({[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propyl]carbamoyl}oxy)ethyl]amino)ethoxy]carbonyl}amino)-4-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid CAS 2765424-50-6 结构式 Chemical Structure

产品介绍 Description

（英文名 (4S)-4-({[2-({[({2-[2-({[({[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]methoxy}carbonyl)amino]sulfonyl}amino)ethoxy]ethoxy}carbonyl)amino]sulfonyl}[2-({[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propyl]carbamoyl}oxy)ethyl]amino)ethoxy]carbonyl}amino)-4-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid，CAS 2765424-50-6）属于药物标准品。分子式 C112H130F2N18O35S2，分子量 2390.46。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

化学式为 C112H130F2N18O35S2 的（(4S)-4-({2-({({2-2-({({(1R,8S,9R)-bicyclo6.1.0non-4-yn-9-ylmethoxy}carbonyl)aminosulfonyl}amino)ethoxyethoxy}carbonyl)aminosulfonyl}2-({(1S)-3-carboxy-1-{(1S)-1-{(1S)-1-({4-({(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-ylcarbamoyl}oxy)methylphenyl}carbamoyl)ethylcarbamoyl}-2-methylpropylcarbamoyl}propylcarbamoyl}oxy)ethylamino)

应用场景：（(4S)-4-({ 2-({ ({2- 2-({ ({ (1R,8S,9R)-bicyclo 6.1.0 non-4-yn-9-yl methoxy}carbonyl)amino sulfonyl}amino)ethoxy ethoxy}carbonyl)amino sulfonyl} 2-({ (1S)-3-carboxy-1-{ (1S)-1-{ (1S)-1-({4- ({ (10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo 14.7.1.0²,¹⁴.0⁴,¹³.0⁶

理化性质 Physical & Chemical Properties

中文名称
分子式C112H130F2N18O35S2
分子量2390.46 g/mol
外观形态淡黄色至黄色无定形粉末。（具有轻微卤代物特征气味，含硫化合物特征性气味，挥发性较低）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）56.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）2003年
卤素含量F取代
含氮原子数18
含硫原子数2

相关专利 Related Patents

  1. Chen K W, Williams B T, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 11663038 B2, 2016-01-20.
  2. Schröder R, Patel M V, Klinger H. "Method for the Synthesis of (4S)-4-({[2-({[({2-[2-({[({[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]methoxy}carbonyl)amino]sulfonyl}amino)ethoxy]ethoxy}carbonyl)amino]sulfonyl}[2-({[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propyl]carbamoyl}oxy)ethyl]amino)ethoxy]carbonyl}amino)-4-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid" [P]. US Patent, US 9991537 B2, 2020-10-15.
  3. 发明人罗永刚，孙丽萍，李文辉. "A Process for Preparing High-Purity (4S)-4-({[2-({[({2-[2-({[({[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]methoxy}carbonyl)amino]sulfonyl}amino)ethoxy]ethoxy}carbonyl)amino]sulfonyl}[2-({[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propyl]carbamoyl}oxy)ethyl]amino)ethoxy]carbonyl}amino)-4-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid" [P]. 中国发明专利, 专利号 CN 113966458 A, 授权公告日 2023-03-15.

参考文献 Literature

  1. Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2022, 1252, (9), 7464-7480.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2017, 953, (8), 2210-2239.
  3. Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of (4S)-4-({[2-({[({2-[2-({[({[(1R,8S,9R)-bicyclo[6.1.0]non-4-yn-9-yl]methoxy}carbonyl)amino]sulfonyl}amino)ethoxy]ethoxy}carbonyl)amino]sulfonyl}[2-({[(1S)-3-carboxy-1-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propyl]carbamoyl}oxy)ethyl]amino)ethoxy]carbonyl}amino)-4-{[(1S)-1-{[(1S)-1-({4-[({[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.0²,¹⁴.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]carbamoyl}oxy)methyl]phenyl}carbamoyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2015, 1255, (4), 1777-1798.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...